Click here for an archive of Jim Cramer's Mad Money recaps.

Despite the passage of federal bailout package, Jim Cramer told viewers of his "Mad Money" TV show that he did not trust this market.

He reminded investors to sell into any moments of strength and play defensively as the details of the bailout plan begin to play out.

Cramer then shifted his attention to Wachovia ( WB), saying its shareholders have good reason for hope after some nifty behind-the-scene moves by CEO Bob Steel.

Cramer praised Steel for working out a deal with Wells Fargo ( WFC).

He admitted he was wrong when he placed Steel on his "Wall of Shame" list of the worst CEOs on Monday. He said he did so because he was disheartened by the federal government's decision to sell Wachovia's assets to Citigroup ( C) and the fact that Steel had not come forward to defend his position.

However, after today's announcement of a deal with Wells Fargo, Cramer said he had an entirely different view of Steel.

Cramer: Being Too Negative Hurts

Cramer credited the CEO for putting his company before his own reputation and staying quiet while the Wells Fargo deal was being done. "I thought the shareholders were finished," he said, "but now there's hope." He added that Steel should be commended for not quitting and giving up on his company.

Filling the empty slot in the Wall of Shame, Cramer added Sen. Harry Reid (D., Nev.) for a comment he made Wednesday that a major insurance company was preparing for bankruptcy.

Cramer said that irresponsible comment caused the stocks of Prudential ( PRU), MetLife ( MET) and Hartford ( HIG) to suffer double-digit percentage drops.

Cramer said Reid deserved to be on the Wall of Shame for adding fear to an already fearful market.

Biotech Shines

Cramer spoke with Henry Termeer, chairman and CEO of Genzyme ( GENZ) to find out if the biotech stock has what it takes to be a recession-proof stock.


Since Cramer last recommended Genzyme on August 12 at $79 a share, the stock is down just 3.8% in a turbulent market. But he said he's now high on Genzyme's prospects since biotech companies often shine during recessions and should fair even better if a Democrat assumes the White House.

Termeer noted that Genzyme's strategy is different from that of most other biotechs, in that the company focuses exclusively on "orphan" drugs, or drugs for rare diseases or diseases where there are no other treatments. He said that while these markets are small, patients often start treatments and stay on them for life, creating a stable earnings for the company.

Termeer also said insurance companies are often not resistant to paying for these treatments since they work well and are often the only option available. He said that while the FDA remains a big, complex hurdle for drug approvals, Genzyme is managing the process effectively.

Cramer said he likes Genzyme for its diversification into drugs in larger markets such as cholesterol, MS and renal failure. Termeer confirmed that the company does have drugs in late stage testing in all these areas.

A New Metric

While Cramer remains bearish on the market as a whole, he's now beginning to prepare for the situation to improve. He continues to look for value in stocks that have been relentlessly beaten down by seemingly endless hedge fund redemptions. One sector that's been hit especially hard are the industrials.

Cramer said he's evaluating the industrial stocks by two simple measures: their dividend yield and how much cash they have on the balance sheet. Earlier in the week, he recommended KBR ( KBR), a company where two-fifths of its marketcap is cash.

Tonight he recommended two other companies that he says are approaching the "value" threshold. The first on his radar screen is steelmaker Nucor ( NUE), with its 3.6% dividend yield. The company was downgraded today by an analyst at Merrill Lynch. With a share price below $30, Cramer said Nucor is solid value stock.

Cramer also recommended Freeport McMoran ( FCX), a stock which he owns for his charitable trust, Action Alerts PLUS , as another company close to a value moniker. With a 4.4% dividend yield, Cramer said he's beginning to buy additional shares to reinforce his position for his trust.

Admittedly, Cramer said gold and steel prices continue to fall, but in the case of Freeport, the stock has fallen from a high of $127 to $44 today. With such a decline, Cramer believes the downside has to be minimal going forward.

Mad Mail

In this segment, Cramer told a viewer that he's not recommending any insurance companies, including Manulife ( MFC).

Cramer told a second viewer that McDermott ( MDR) is too low to sell, but with continued hedge fund selling, he's still not a buyer of the company yet.

Lightning Round

Cramer was bullish on Starbucks ( SBUX) and Waste Management ( WMI).

He was bearish on Computer Sciences ( CSC), Boyd Gaming ( BYD), Las Vegas Sands ( LVS), Wynn Resorts ( WYNN), Energy Recovery ( ERII), EMCOR Group ( EME), Green Mountain Coffee Roasters ( GMCR), Vishay Intertechnology ( VSH), Mosaic ( MOS), Sovereign Bancorp ( SOV) and Zimmer Holdings ( ZMH).

Where will the Dow Jones Industrial Average stand at the end of 2008? Above 10,000 9000-10,000 8000-9000 7000-8000 Below 7000

Where will the Dow Jones Industrial Average stand at the end of 2008?

Above 10,000
7000 to 8000
Below 7000

Want more Cramer? Check out Jim's rules and commandments for investing by clicking here.

Read more of Cramer's Mad Money Lightning Round insights.

For "Mad Money" performance statistics and other links, check out Mad Money stats
At the time of publication, Cramer was long Freeport McMoRan.

Jim Cramer, host of the CNBC television program "Mad Money," is a Markets Commentator for, Inc., and CNBC, and a director and co-founder of All opinions expressed by Mr. Cramer on "Mad Money" are his own and do not reflect the opinions of or its affiliates, or CNBC, NBC UNIVERSAL or their parent company or affiliates. Mr. Cramer's opinions are based upon information he considers to be reliable, but neither, nor CNBC, nor either of their affiliates and/or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. Mr. Cramer's statements are based on his opinions at the time statements are made, and are subject to change without notice. No part of Mr. Cramer's compensation from CNBC or is related to the specific opinions expressed by him on "Mad Money."

None of the information contained in "Mad Money" constitutes a recommendation by Mr. Cramer, or CNBC that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the program. Mr. Cramer's past results are not necessarily indicative of future performance. Neither Mr. Cramer, nor, nor CNBC guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the program. The strategy or investments discussed may fluctuate in price or value and you may get back less than you invested. Before acting on any information contained in the program, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Some of the stocks mentioned by Mr. Cramer on "Mad Money" are held in Mr. Cramer's Action Alerts PLUS Portfolio. When that is the case, appropriate disclosure is made on the program and in the "Mad Money" recap available on The Action Alerts PLUS Portfolio contains all of Mr. Cramer's personal investments in publicly-traded equity securities only, and does not include any mutual fund holdings or other institutionally managed assets, private equity investments, or his holdings in, Inc. Since March 2005, the Action Alerts PLUS Portfolio has been held by a Trust, the realized profits from which have been pledged to charity. Mr. Cramer retains full investment discretion with respect to all securities contained in the Trust. Mr. Cramer is subject to certain trading restrictions, and must hold all securities in the Action Alerts PLUS Portfolio for at least one month, and is not permitted to buy or sell any security he has spoken about on television or on his radio program for five days following the broadcast.

If you liked this article you might like

Chopping a Way Back for the Bull: Cramer's 'Mad Money' Recap (Tuesday 3/21/18)

Chopping a Way Back for the Bull: Cramer's 'Mad Money' Recap (Tuesday 3/21/18)

Take-Two Interactive, Constellation Brands: 'Mad Money' Lightning Round

Take-Two Interactive, Constellation Brands: 'Mad Money' Lightning Round

Cigna and Express Scripts: Cramer's Top Takeaways

Cigna and Express Scripts: Cramer's Top Takeaways

Emerson Electric: Cramer's Top Takeaways

Emerson Electric: Cramer's Top Takeaways

Camping World, Lam Research, Oclaro: 'Mad Money' Lightning Round

Camping World, Lam Research, Oclaro: 'Mad Money' Lightning Round